Skip to main content
Erschienen in: Endocrine 3/2018

17.07.2018 | Original Article

Lack of functional remission in Cushing’s syndrome

verfasst von: M. Vermalle, M. Alessandrini, T. Graillon, N. C Paladino, K. Baumstarck, F. Sebag, H. Dufour, T. Brue, F. Castinetti

Erschienen in: Endocrine | Ausgabe 3/2018

Einloggen, um Zugang zu erhalten

Abstract

Introduction

Hypercortisolism leads to severe clinical consequences persisting after the onset of remission. These physical sequelae of cortisol exposure are known to profoundly impact the patient’s quality of life. As psychological factors may be correlated with this quality of life, our objective was to determine the specific weight of psychological determinants of quality of life in patients in remission from hypercortisolism.

Patients and methods

In an observational study, 63 patients with hypercortisolism in remission were asked to complete exhaustive self-administered questionnaires including quality of life (WHOQoL-BREF and Cushing QoL), depression, anxiety, self-esteem, body image, and coping scales. Multivariate analyses were performed. Psychological variables relevant to the model were: anxiety, depression, self-esteem, body image, and positive thinking dimension of the Brief-COPE. Cortisol deficiency was defined as a potential confounder.

Results

The median time since remission was 3 years. Patients had significantly lower quality of life and body satisfaction score than the French population and patients with chronic diseases. Depression significantly impaired all WHOQoL and Cushing QoL domains. A low body satisfaction score significantly impaired social relationships quality of life score. In total, 42.9% of patients still needed working arrangements, 19% had disability or cessation of work.

Conclusion

Patients in biological remission of hypercortisolism can rarely be considered as functionally cured: this is evidenced by altered quality of life, working arrangements, and chronic depression. A multidisciplinary management of these patients is thus mandatory on a long-term basis.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
2.
Zurück zum Zitat J.K. Lambert, L. Goldberg, S. Fayngold, J. Kostadinov, K.D. Post, E.B. Geer, Predictors of mortality and long-term outcomes in treated Cushing’s disease: a study of 346 patients. J. Clin. Endocrinol. Metab. 98(3), 1022–1030 (2013)CrossRefPubMedPubMedCentral J.K. Lambert, L. Goldberg, S. Fayngold, J. Kostadinov, K.D. Post, E.B. Geer, Predictors of mortality and long-term outcomes in treated Cushing’s disease: a study of 346 patients. J. Clin. Endocrinol. Metab. 98(3), 1022–1030 (2013)CrossRefPubMedPubMedCentral
3.
4.
Zurück zum Zitat L.D. Dorn, E.S. Burgess, T.C. Friedman, B. Dubbert, P.W. Gold, G.P. Chrousos, The longitudinal course of psychopathology in Cushing’s syndrome after correction of hypercortisolism. J. Clin. Endocrinol. Metab. 82(3), 912–919 (1997)PubMed L.D. Dorn, E.S. Burgess, T.C. Friedman, B. Dubbert, P.W. Gold, G.P. Chrousos, The longitudinal course of psychopathology in Cushing’s syndrome after correction of hypercortisolism. J. Clin. Endocrinol. Metab. 82(3), 912–919 (1997)PubMed
5.
Zurück zum Zitat O.M. Dekkers, E. Horvath-Puho, J.O. Jorgensen, S.C. Cannegieter, V. Ehrenstein, J.P. Vandenbroucke et al.Multisystem morbidity and mortality in Cushing’s syndrome: a cohort study. J. Clin. Endocrinol. Metab. 98(6), 2277–2284 (2013)CrossRefPubMed O.M. Dekkers, E. Horvath-Puho, J.O. Jorgensen, S.C. Cannegieter, V. Ehrenstein, J.P. Vandenbroucke et al.Multisystem morbidity and mortality in Cushing’s syndrome: a cohort study. J. Clin. Endocrinol. Metab. 98(6), 2277–2284 (2013)CrossRefPubMed
6.
Zurück zum Zitat M. Terzolo, B. Allasino, A. Pia, G. Peraga, F. Daffara, F. Laino et al.Surgical remission of Cushing’s syndrome reduces cardiovascular risk. Eur. J. Endocrinol. 171(1), 127–136 (2014)CrossRefPubMed M. Terzolo, B. Allasino, A. Pia, G. Peraga, F. Daffara, F. Laino et al.Surgical remission of Cushing’s syndrome reduces cardiovascular risk. Eur. J. Endocrinol. 171(1), 127–136 (2014)CrossRefPubMed
7.
Zurück zum Zitat R. Pivonello, A. Faggiano, G. Lombardi, A. Colao, The metabolic syndrome and cardiovascular risk in Cushing’s syndrome. Endocrinol. Metab. Clin. North. Am. 34(2), 327–339 (2005). viiiCrossRefPubMed R. Pivonello, A. Faggiano, G. Lombardi, A. Colao, The metabolic syndrome and cardiovascular risk in Cushing’s syndrome. Endocrinol. Metab. Clin. North. Am. 34(2), 327–339 (2005). viiiCrossRefPubMed
8.
Zurück zum Zitat A. Colao, R. Pivonello, S. Spiezia, A. Faggiano, D. Ferone, M. Filippella et al.Persistence of increased cardiovascular risk in patients with Cushing’s disease after five years of successful cure. J. Clin. Endocrinol. Metab. 84(8), 2664–2672 (1999)PubMed A. Colao, R. Pivonello, S. Spiezia, A. Faggiano, D. Ferone, M. Filippella et al.Persistence of increased cardiovascular risk in patients with Cushing’s disease after five years of successful cure. J. Clin. Endocrinol. Metab. 84(8), 2664–2672 (1999)PubMed
9.
Zurück zum Zitat A.M. Pereira, J. Tiemensma, J.A. Romijn, Neuropsychiatric disorders in Cushing’s syndrome. Neuroendocrinology 92(Suppl 1), 65–70 (2010)CrossRefPubMed A.M. Pereira, J. Tiemensma, J.A. Romijn, Neuropsychiatric disorders in Cushing’s syndrome. Neuroendocrinology 92(Suppl 1), 65–70 (2010)CrossRefPubMed
10.
Zurück zum Zitat M.A. Wagenmakers, R.T. Netea-Maier, J.B. Prins, T. Dekkers, M. den Heijer, A.R. Hermus, Impaired quality of life in patients in long-term remission of Cushing’s syndrome of both adrenal and pituitary origin: a remaining effect of long-standing hypercortisolism? Eur. J. Endocrinol. 167(5), 687–695 (2012)CrossRefPubMed M.A. Wagenmakers, R.T. Netea-Maier, J.B. Prins, T. Dekkers, M. den Heijer, A.R. Hermus, Impaired quality of life in patients in long-term remission of Cushing’s syndrome of both adrenal and pituitary origin: a remaining effect of long-standing hypercortisolism? Eur. J. Endocrinol. 167(5), 687–695 (2012)CrossRefPubMed
11.
Zurück zum Zitat J. Tiemensma, A.A. Kaptein, A.M. Pereira, J.W. Smit, J.A. Romijn, N.R. Biermasz, Negative illness perceptions are associated with impaired quality of life in patients after long-term remission of Cushing’s syndrome. Eur. J. Endocrinol. 165(4), 527–535 (2011)CrossRefPubMed J. Tiemensma, A.A. Kaptein, A.M. Pereira, J.W. Smit, J.A. Romijn, N.R. Biermasz, Negative illness perceptions are associated with impaired quality of life in patients after long-term remission of Cushing’s syndrome. Eur. J. Endocrinol. 165(4), 527–535 (2011)CrossRefPubMed
12.
Zurück zum Zitat Development of the World Health Organization WHOQOL-BREF quality of life assessment, The WHOQOL Group. Psychol. Med. 28(3), 551–558 (1998)CrossRef Development of the World Health Organization WHOQOL-BREF quality of life assessment, The WHOQOL Group. Psychol. Med. 28(3), 551–558 (1998)CrossRef
13.
Zurück zum Zitat C. Baumann, M.L. Erpelding, S. Regat, J.F. Collin, S. Briancon, The WHOQOL-BREF questionnaire: French adult population norms for the physical health, psychological health and social relationship dimensions. Rev. Epidemiol. Sante Publique 58(1), 33–39 (2010)CrossRefPubMed C. Baumann, M.L. Erpelding, S. Regat, J.F. Collin, S. Briancon, The WHOQOL-BREF questionnaire: French adult population norms for the physical health, psychological health and social relationship dimensions. Rev. Epidemiol. Sante Publique 58(1), 33–39 (2010)CrossRefPubMed
14.
Zurück zum Zitat S.M. Webb, X. Badia, M.J. Barahona, A. Colao, C.J. Strasburger, A. Tabarin et al.Evaluation of health-related quality of life in patients with Cushing’s syndrome with a new questionnaire. Eur. J. Endocrinol. 158(5), 623–630 (2008)CrossRefPubMed S.M. Webb, X. Badia, M.J. Barahona, A. Colao, C.J. Strasburger, A. Tabarin et al.Evaluation of health-related quality of life in patients with Cushing’s syndrome with a new questionnaire. Eur. J. Endocrinol. 158(5), 623–630 (2008)CrossRefPubMed
15.
Zurück zum Zitat A.S. Zigmond, R.P. Snaith, The hospital anxiety and depression scale. Acta Psychiatr. Scand. 67(6), 361–370 (1983)CrossRefPubMed A.S. Zigmond, R.P. Snaith, The hospital anxiety and depression scale. Acta Psychiatr. Scand. 67(6), 361–370 (1983)CrossRefPubMed
16.
Zurück zum Zitat J.P. Lepine, M. Godchau, P. Brun, T. Lemperiere, [Evaluation of anxiety and depression among patients hospitalized on an internal medicine service]. Ann. Med. Psychol. (Paris) 143(2), 175–189 (1985) J.P. Lepine, M. Godchau, P. Brun, T. Lemperiere, [Evaluation of anxiety and depression among patients hospitalized on an internal medicine service]. Ann. Med. Psychol. (Paris) 143(2), 175–189 (1985)
17.
Zurück zum Zitat Rosenberg M. Society and the Adolescent Self-Image. Princeton: Princeton University Press. 1965. Rosenberg M. Society and the Adolescent Self-Image. Princeton: Princeton University Press. 1965.
18.
Zurück zum Zitat E. Vallieres, R. Vallerand, Traduction et Validation Canadienne-Française de L’échelle de L’estime de Soi de Rosenberg. Int. J. Psychol. 25(2), 305–316 (1990)CrossRef E. Vallieres, R. Vallerand, Traduction et Validation Canadienne-Française de L’échelle de L’estime de Soi de Rosenberg. Int. J. Psychol. 25(2), 305–316 (1990)CrossRef
19.
Zurück zum Zitat M. Koleck, M. Bruchon-Schweitzer, F. Cousson-Gelie, J. Gilliard, B. Quintard, The body-image questionnaire: an extension. Percept. Mot. Skills 94(1), 189–196 (2002)CrossRefPubMed M. Koleck, M. Bruchon-Schweitzer, F. Cousson-Gelie, J. Gilliard, B. Quintard, The body-image questionnaire: an extension. Percept. Mot. Skills 94(1), 189–196 (2002)CrossRefPubMed
20.
Zurück zum Zitat Lazarus R., Folkman S. Stress, appraisal, and coping: New York: Springer; 1984. Lazarus R., Folkman S. Stress, appraisal, and coping: New York: Springer; 1984.
21.
Zurück zum Zitat L. Muller, E. Spitz, [Multidimensional assessment of coping: validation of the Brief COPE among French population]. Encephale 29(6), 507–518 (2003)PubMed L. Muller, E. Spitz, [Multidimensional assessment of coping: validation of the Brief COPE among French population]. Encephale 29(6), 507–518 (2003)PubMed
22.
Zurück zum Zitat K. Baumstarck, M. Alessandrini, Z. Hamidou, P. Auquier, T. Leroy, L. Boyer, Assessment of coping: a new french four-factor structure of the brief COPE inventory. Health Qual. Life Outcomes 15(1), 8 (2017)CrossRefPubMedPubMedCentral K. Baumstarck, M. Alessandrini, Z. Hamidou, P. Auquier, T. Leroy, L. Boyer, Assessment of coping: a new french four-factor structure of the brief COPE inventory. Health Qual. Life Outcomes 15(1), 8 (2017)CrossRefPubMedPubMedCentral
23.
Zurück zum Zitat P. Pires, A. Santos, Y. Vives-Gilabert, S.M. Webb, A. Sainz-Ruiz, E. Resmini et al. White matter involvement on DTI-MRI in Cushing’s syndrome relates to mood disturbances and processing speed: a case-control study. Pituitary 20(3), 340–348 (2017)CrossRefPubMed P. Pires, A. Santos, Y. Vives-Gilabert, S.M. Webb, A. Sainz-Ruiz, E. Resmini et al. White matter involvement on DTI-MRI in Cushing’s syndrome relates to mood disturbances and processing speed: a case-control study. Pituitary 20(3), 340–348 (2017)CrossRefPubMed
24.
Zurück zum Zitat M. Tohen, J. Hennen, C.M. Zarate Jr., R.J. Baldessarini, S.M. Strakowski, A.L. Stoll et al. Two-year syndromal and functional recovery in 219 cases of first-episode major affective disorder with psychotic features. Am. J. Psychiatry 157(2), 220–228 (2000)CrossRefPubMed M. Tohen, J. Hennen, C.M. Zarate Jr., R.J. Baldessarini, S.M. Strakowski, A.L. Stoll et al. Two-year syndromal and functional recovery in 219 cases of first-episode major affective disorder with psychotic features. Am. J. Psychiatry 157(2), 220–228 (2000)CrossRefPubMed
25.
Zurück zum Zitat A. Santos, E. Resmini, J.C. Pascual, I. Crespo, S.M. Webb, Psychiatric symptoms in patients with Cushing’s syndrome: prevalence, diagnosis and management. Drugs 77(8), 829–842 (2017)CrossRefPubMed A. Santos, E. Resmini, J.C. Pascual, I. Crespo, S.M. Webb, Psychiatric symptoms in patients with Cushing’s syndrome: prevalence, diagnosis and management. Drugs 77(8), 829–842 (2017)CrossRefPubMed
26.
Zurück zum Zitat L.M. Nelson, A. Forsythe, L. McLeod, S. Pulgar, M. Maldonado, T. Coles et al. Psychometric evaluation of the Cushing’s Quality-of-Life questionnaire. Patient 6(2), 113–124 (2013)CrossRefPubMed L.M. Nelson, A. Forsythe, L. McLeod, S. Pulgar, M. Maldonado, T. Coles et al. Psychometric evaluation of the Cushing’s Quality-of-Life questionnaire. Patient 6(2), 113–124 (2013)CrossRefPubMed
27.
Zurück zum Zitat K.A. Phillips, S.A. Rasmussen, Change in psychosocial functioning and quality of life of patients with body dysmorphic disorder treated with fluoxetine: a placebo-controlled study. Psychosomatics 45(5), 438–444 (2004)CrossRefPubMedPubMedCentral K.A. Phillips, S.A. Rasmussen, Change in psychosocial functioning and quality of life of patients with body dysmorphic disorder treated with fluoxetine: a placebo-controlled study. Psychosomatics 45(5), 438–444 (2004)CrossRefPubMedPubMedCentral
28.
Zurück zum Zitat S. Choi-Kwon, J. Choi, S.U. Kwon, D.W. Kang, J.S. Kim, Fluoxetine improves the quality of life in patients with poststroke emotional disturbances. Cerebrovasc. Dis. 26(3), 266–271 (2008)CrossRefPubMed S. Choi-Kwon, J. Choi, S.U. Kwon, D.W. Kang, J.S. Kim, Fluoxetine improves the quality of life in patients with poststroke emotional disturbances. Cerebrovasc. Dis. 26(3), 266–271 (2008)CrossRefPubMed
29.
Zurück zum Zitat T. Toffanin, F. Nifosi, H. Follador, A. Passamani, F. Zonta, G. Ferri et al. Volumetric MRI analysis of hippocampal subregions in Cushing’s disease: a model for glucocorticoid neural modulation. Eur. Psychiatry 26(1), 64–67 (2011)CrossRefPubMed T. Toffanin, F. Nifosi, H. Follador, A. Passamani, F. Zonta, G. Ferri et al. Volumetric MRI analysis of hippocampal subregions in Cushing’s disease: a model for glucocorticoid neural modulation. Eur. Psychiatry 26(1), 64–67 (2011)CrossRefPubMed
30.
Zurück zum Zitat E. Resmini, A. Santos, B. Gomez-Anson, O. Lopez-Mourelo, P. Pires, Y. Vives-Gilabert et al. Hippocampal dysfunction in cured Cushing’s syndrome patients, detected by (1) H-MR-spectroscopy. Clin. Endocrinol. (Oxf.). 79(5), 700–707 (2013)PubMed E. Resmini, A. Santos, B. Gomez-Anson, O. Lopez-Mourelo, P. Pires, Y. Vives-Gilabert et al. Hippocampal dysfunction in cured Cushing’s syndrome patients, detected by (1) H-MR-spectroscopy. Clin. Endocrinol. (Oxf.). 79(5), 700–707 (2013)PubMed
31.
Zurück zum Zitat J.M. Launay, S. Mouillet-Richard, A. Baudry, M. Pietri, O. Kellermann, Raphe-mediated signals control the hippocampal response to SRI antidepressants via miR-16. Transl. Psychiatry 1, e56 (2011)CrossRefPubMedPubMedCentral J.M. Launay, S. Mouillet-Richard, A. Baudry, M. Pietri, O. Kellermann, Raphe-mediated signals control the hippocampal response to SRI antidepressants via miR-16. Transl. Psychiatry 1, e56 (2011)CrossRefPubMedPubMedCentral
32.
Zurück zum Zitat J. Tiemensma, N.P. Daskalakis, E.M. van der Veen, S. Ramondt, S.K. Richardson, E. Broadbent et al. Drawings reflect a new dimension of the psychological impact of long-term remission of Cushing’s syndrome. J. Clin. Endocrinol. Metab. 97(9), 3123–3131 (2012)CrossRefPubMed J. Tiemensma, N.P. Daskalakis, E.M. van der Veen, S. Ramondt, S.K. Richardson, E. Broadbent et al. Drawings reflect a new dimension of the psychological impact of long-term remission of Cushing’s syndrome. J. Clin. Endocrinol. Metab. 97(9), 3123–3131 (2012)CrossRefPubMed
33.
Zurück zum Zitat S.B. Abraham, B.S. Abel, D. Rubino, T. Nansel, S. Ramsey, L.K. Nieman, A direct comparison of quality of life in obese and Cushing’s syndrome patients. Eur. J. Endocrinol. 168(5), 787–793 (2013)CrossRefPubMedPubMedCentral S.B. Abraham, B.S. Abel, D. Rubino, T. Nansel, S. Ramsey, L.K. Nieman, A direct comparison of quality of life in obese and Cushing’s syndrome patients. Eur. J. Endocrinol. 168(5), 787–793 (2013)CrossRefPubMedPubMedCentral
34.
Zurück zum Zitat E.B. Geer, Y. Lalazar, L.M. Couto, V. Cohen, L.R. Lipton, W. Shi et al. A prospective study of appetite and food craving in 30 patients with Cushing’s disease. Pituitary 19(2), 117–126 (2016)CrossRefPubMedPubMedCentral E.B. Geer, Y. Lalazar, L.M. Couto, V. Cohen, L.R. Lipton, W. Shi et al. A prospective study of appetite and food craving in 30 patients with Cushing’s disease. Pituitary 19(2), 117–126 (2016)CrossRefPubMedPubMedCentral
35.
Zurück zum Zitat C. De Bucy, L. Guignat, T. Niati, J. Bertherat, J. Coste, Health-related quality of life of patients with hypothalamic-pituitary-adrenal axis dysregulations: a cohort study. Eur. J. Endocrinol. 177(1), 1–8 (2017)CrossRefPubMed C. De Bucy, L. Guignat, T. Niati, J. Bertherat, J. Coste, Health-related quality of life of patients with hypothalamic-pituitary-adrenal axis dysregulations: a cohort study. Eur. J. Endocrinol. 177(1), 1–8 (2017)CrossRefPubMed
36.
Zurück zum Zitat S. Bensing, A.L. Hulting, E.S. Husebye, O. Kampe, K. Lovas, MANAGEMENT OF ENDOCRINE DISEASE: Epidemiology, quality of life and complications of primary adrenal insufficiency: a review. Eur. J. Endocrinol. 175(3), R107–R116 (2016)CrossRefPubMed S. Bensing, A.L. Hulting, E.S. Husebye, O. Kampe, K. Lovas, MANAGEMENT OF ENDOCRINE DISEASE: Epidemiology, quality of life and complications of primary adrenal insufficiency: a review. Eur. J. Endocrinol. 175(3), R107–R116 (2016)CrossRefPubMed
37.
Zurück zum Zitat J. Tiemensma, C.D. Andela, A.A. Kaptein, J.A. Romijn, R.C. van der Mast, N.R. Biermasz et al. Psychological morbidity and impaired quality of life in patients with stable treatment for primary adrenal insufficiency: cross-sectional study and review of the literature. Eur. J. Endocrinol. 171(2), 171–182 (2014)CrossRefPubMed J. Tiemensma, C.D. Andela, A.A. Kaptein, J.A. Romijn, R.C. van der Mast, N.R. Biermasz et al. Psychological morbidity and impaired quality of life in patients with stable treatment for primary adrenal insufficiency: cross-sectional study and review of the literature. Eur. J. Endocrinol. 171(2), 171–182 (2014)CrossRefPubMed
38.
Zurück zum Zitat S.R. Kesler, H.F. Adams, C.M. Blasey, E.D. Bigler, Premorbid intellectual functioning, education, and brain size in traumatic brain injury: an investigation of the cognitive reserve hypothesis. Appl. Neuropsychol. 10(3), 153–162 (2003)CrossRefPubMed S.R. Kesler, H.F. Adams, C.M. Blasey, E.D. Bigler, Premorbid intellectual functioning, education, and brain size in traumatic brain injury: an investigation of the cognitive reserve hypothesis. Appl. Neuropsychol. 10(3), 153–162 (2003)CrossRefPubMed
40.
Zurück zum Zitat Y. Stern, The concept of cognitive reserve: a catalyst for research. J. Clin. Exp. Neuropsychol. 25(5), 589–593 (2003)CrossRefPubMed Y. Stern, The concept of cognitive reserve: a catalyst for research. J. Clin. Exp. Neuropsychol. 25(5), 589–593 (2003)CrossRefPubMed
Metadaten
Titel
Lack of functional remission in Cushing’s syndrome
verfasst von
M. Vermalle
M. Alessandrini
T. Graillon
N. C Paladino
K. Baumstarck
F. Sebag
H. Dufour
T. Brue
F. Castinetti
Publikationsdatum
17.07.2018
Verlag
Springer US
Erschienen in
Endocrine / Ausgabe 3/2018
Print ISSN: 1355-008X
Elektronische ISSN: 1559-0100
DOI
https://doi.org/10.1007/s12020-018-1664-7

Weitere Artikel der Ausgabe 3/2018

Endocrine 3/2018 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.